共 50 条
- [31] Anti-CD123 CAR T-Cell Therapy for the Treatment of Myelodysplastic SyndromeBLOOD, 2017, 130Zhang, WeiStevens, Brett M.Budde, Elizabeth ElizabethForman, Stephen J.Jordan, Craig T.Purev, Enkhtsetseg
- [32] Severe cytokine release syndrome is associated with hematologic toxicity following CD19 CAR T-cell therapyBLOOD ADVANCES, 2022, 6 (07) : 2055 - 2068Juluri, Krishna R.Wu, Qian VickyVoutsinas, JennaHou, JueHirayama, Alexandre, VMullane, ErinMiles, NancyMaloney, David G.Turtle, Cameron J.Bar, MeravGauthier, Jordan
- [33] KMT2A Rearrangements Are Associated with Lineage Switch Following CD19 Targeting CAR T-Cell TherapyBLOOD, 2021, 138Lamble, Adam J.Myers, Regina M.Taraseviciute, AgneJohn, SamuelYates, BonnieSteinberg, Seth M.Sheppard, JenniferKovach, Alexandra E.Wood, Brent L.Borowitz, MichaelYuan, Constance M.Pillai, VinodhFoley, ToniChung, PerryChen, LeeLee, Daniel W.Annesley, ColleenDiNofia, Amanda M.Grupp, Stephan A.Verneris, Michael R.Gore, LiaLaetsch, Theodore W.Bhojwani, DeepaBrown, Patrick A.Pulsipher, Michael A.Rheingold, Susan R.Gardner, Rebecca A.Shah, Nirali N.
- [34] Targeting autoimmunity with CD19-CAR T-cell therapy: efficacy and seroconversion in diffuse systemic sclerosis and rheumatoid arthritisRHEUMATOLOGY, 2025,Albach, Fredrik N.Minopoulou, IoannaWilhelm, ArturBiesen, RobertKleyer, ArndWiebe, EdgarFleischmann, AnjaFrick, MareikeDamm, FrederikGogolok, JuliaServe, SebastianLocher, Benjamin NickBorie, DominicCasteleyn, VincentSiegert, EliseDoerner, ThomasAlexander, TobiasFurth, ChristianZernicke, JanMovassaghi, KamranHuetter-Kroenke, Marie LuiseSchrezenmeier, EvaSchneider, UdoBullinger, LarsKroenke, GerhardPenack, OlafSimon, David
- [35] CD19/CD22 targeting with cotransduced CAR T cells to prevent antigen-negative relapse after CAR T-cell therapy for B-cell ALLBLOOD, 2024, 143 (02) : 118 - 123Ghorashian, SaraLucchini, GiovannaRichardson, RachelNguyen, KyviTerris, CraigGuvenel, AleksOporto-Espuelas, MacarenaYeung, JennyPinner, DanielleChu, JanWilliams, LindseyKo, Ka-YukWalding, ChloeWatts, KellyInglott, SarahThomas, RebeccaConnor, ChristopherAdams, StuartGravett, EmmaGilmour, KimberlyLal, AlkaKunaseelan, SangeethaPopova, BilyanaLopes, AndreNgai, YentingHackshaw, AllanKokalaki, EvangeliaCarulla, Milena BalaschMullan, KhushnumaLazareva, ArinaPavasovic, VesnaRao, AnupamaBartram, JackVora, AjayChiesa, RobertSilva, JulianaRao, KanchanBonney, DeniseWynn, RobertPule, MartinHough, RachaelAmrolia, Persis J.
- [36] Clinical features of neurotoxicity after CD19 CAR T-cell therapy in mantle cellBLOOD ADVANCES, 2024, 8 (06) : 1474 - 1486Nie, Esther H.Su, Yi-JiunBaird, John H.Agarwal, NehaBharadwaj, SushmaWeng, Wen-KaiSmith, MelodyDahiya, SaurabhHan, May H.Dunn, Jeffrey E.Kipp, Lucas B.Miklos, David B.Scott, Brian J.Frank, Matthew J.
- [37] TREATMENT OF A PATIENT WITH SEVERE DIFFUSE SYSTEMIC SCLEROSIS (SSC) USING CD19-TARGETING CAR-T-CELLSANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1621 - 1621Bergmann, C.Mueller, F.Joerg, D.Gyoerfi, D. M. H.Voelkl, S.Aigner, M.Harrer, T.Bayerl, N.Atzinger, A.Taubmann, J.Boeltz, S.Wacker, J.Uder, M.Kuwert, T.Andreas, M.Schett, G.
- [38] Cytomegalovirus reactivation after CD19 CAR T-cell therapy is clinically significantHAEMATOLOGICA, 2023, 108 (02) : 615 - 620Chen, GeorgeHerr, MeganNowak, JanHo, ChristineAlmyroudis, NikolaosAttwood, KristopherBonnewell, JohnWalsh, MarissaSegal, BrahmRoss, MaureenMcCarthy, PhilipHahn, Theresa
- [40] CD19-directed CAR T-cell therapy for treatment of primary CNS lymphomaBLOOD ADVANCES, 2021, 5 (20) : 4059 - 4063Siddiqi, TanyaWang, XiuliBlanchard, M. SuzetteWagner, Jamie R.Popplewell, Leslie L.Budde, L. ElizabethStiller, Tracey L.Clark, Mary C.Lim, LauraVyas, VibhutiBrown, Christine E.Forman, Stephen J.